Transcat Inc. filings document material events for a calibration services and test-instrument distribution company. Recent Form 8-K reports cover quarterly results furnished under Item 2.02, earnings press releases and presentation exhibits, and Regulation FD disclosures tied to operating updates.
The company’s filings also record governance and equity-compensation matters, including executive appointments, officer transitions, retention equity awards, and transition agreements. Acquisition-related 8-K disclosures describe completed purchases of calibration laboratory businesses, related material agreements, consideration, exhibits, and customary representations, warranties and holdback provisions.
Transcat, Inc. files its annual report describing a calibration‑focused services and test equipment distribution business aimed at highly regulated industries such as life sciences, aerospace and energy. The company operates two segments, with Service positioned as the main long‑term growth driver.
Transcat runs 33 calibration service centers across North America and Ireland, added a Costa Rica lab in April 2026, and performs over 1.2 million calibrations annually for about 27,000 customers. Recent acquisitions include Essco in fiscal 2026, its largest deal, plus Martin and Becnel in fiscal 2025, all aimed at geographic expansion and capabilities.
The report highlights an Operational Excellence initiative, proprietary CalTrak® and C3® asset management platforms, and a strategy to cross‑sell between Service and Distribution. Key risks center on macroeconomic conditions, intense competition (including online and direct‑from‑vendor channels), acquisition integration, cybersecurity, supply chain disruptions and a $99.9 million debt balance under a $150 million credit facility.
Transcat, Inc. reported strong top-line growth but weaker earnings for its fiscal fourth quarter and full year ended March 28, 2026. Q4 revenue rose 15.8% to $89.3 million, led by 18.4% growth in service revenue to $61.6 million and 10.5% growth in distribution revenue to $27.8 million. Q4 gross margin improved to 34.1%, and Adjusted EBITDA* increased 16.0% to $14.8 million, but operating income fell 37.6% to $4.3 million and net income declined to $1.9 million, or $0.21 per diluted share.
For fiscal 2026, total revenue grew 19.2% to $331.9 million, with service revenue up 19.7% and distribution revenue up 18.2%. Full‑year gross margin expanded 50 basis points to 32.6% and Adjusted EBITDA* rose 22.7% to $48.7 million, while operating income decreased 25.8% to $13.3 million and net income dropped 63.0% to $5.4 million, or $0.57 per diluted share. Management attributes higher operating expenses to acquisitions, increased amortization, stock-based compensation, executive transition costs and incentives, and continues to guide to high single-digit service organic revenue growth for fiscal 2027.
Transcat, Inc. reported a change to executive compensation for its Chief Operating Officer, Michael W. West. Effective as of March 29, 2026, for the fiscal year ending March 27, 2027, Mr. West will receive a base salary of $425,000 per year, a target performance-based cash incentive equal to 40% of base salary, and a target long-term equity incentive equal to 65% of base salary. These elements together define his compensation opportunity for fiscal 2027.
Vanguard Capital Management reports beneficial ownership of 475,732 shares of Transcat Inc Common Stock, equal to 5.09% of the class as of 03/31/2026. The filing states Vanguard exercises sole dispositive power over 475,732 shares and sole voting power over 68,571 shares, and that these holdings include securities held for Vanguard funds and managed accounts.
Transcat, Inc. ownership filing: Royce & Associates reports beneficial ownership of 614,253 shares of Common Stock, representing 6.58% of the class as disclosed on 03/31/2026. The filing states Royce & Associates has sole voting and dispositive power over these shares and disclaims pecuniary interest.
Transcat Inc director and executive Jaime A. Irick has filed an initial insider ownership report. The Form 3 filing lists Irick as both a director and as President and CEO of Transcat Inc, with no insider transactions or derivative positions reported in this filing.
Transcat Inc. ownership filing: Ophir Asset Management Pty Ltd reports beneficial ownership of 482,038 shares of Transcat common stock, equal to 5.2% of the class. The filing breaks the position into two funds: 201,933 shares in Ophir Global Opportunities Fund and 280,105 shares in Ophir High Conviction Fund. The ownership percentage is calculated using 9,332,188 shares outstanding as reported on a Form 8-K filed February 3, 2026.
Transcat Inc. Chief Operating Officer Michael W. West reported routine equity compensation activity involving restricted stock units (RSUs) that converted into common stock. On March 26 and March 28, 2026, RSU awards covering 1,000 and 725 underlying shares, respectively, were exercised into common stock at an exercise price of $0.00 per share.
To cover tax withholding obligations on these RSU vestings, 495 shares were delivered at $72.97 per share and 339 shares at $71.32 per share, as disclosed. After these transactions, West directly held 26,484 shares of Transcat common stock. He also retained multiple outstanding RSU awards that convert one-for-one into common stock, with underlying share amounts including 12,028, 1,286, 2,000 and 916 shares.
Transcat Inc. Sr. VP Finance & CFO Thomas L. Barbato reported routine equity compensation activity involving restricted stock units (RSUs) and common shares. On March 26, 2026, 2,500 RSUs converted into common stock, and on March 28, 2026, an additional 1,186 RSUs converted on a one-for-one basis.
To cover tax withholding obligations on these RSU vestings, the company withheld 1,171 shares at $72.97 per share on March 26 and 524 shares at $71.32 per share on March 28. After these transactions, Barbato directly held 3,690 shares of Transcat common stock.
He also continued to hold unexercised equity awards, including multiple RSU grants covering 19,772, 2,691 and 1,919 underlying shares, as well as stock options for 6,000 shares at an exercise price of $90.92 and 5,000 shares at $63.17, both expiring in 2027.
Transcat Inc. senior vice president of human resources Theresa A. Conroy exercised restricted stock units (RSUs) into common shares and had a portion withheld for taxes. On March 26, 2026, 1,500 RSUs vested and converted one-for-one into common stock, with 743 shares withheld at $72.97 per share to cover tax obligations. On March 28, 2026, another 524 RSUs vested, with 232 shares withheld at $71.32 per share for taxes. Following these transactions, she directly held 1,931 shares of common stock and retained unexercised equity awards, including multiple RSU grants and a fully exercisable stock option for 2,000 shares at an exercise price of $63.17 per share expiring on May 25, 2027. These events reflect routine equity compensation vesting and related tax withholding rather than open-market buying or selling.